References
1. Lever, M. and S. Slow, The
clinical significance of betaine, an osmolyte with a key role in methyl
group metabolism. Clin Biochem, 2010. 43 (9): p. 732-44.
2. Craig, S.A.S., Betaine in
human nutrition. 2004.
3. Zhao, G., et al., Betaine in
Inflammation: Mechanistic Aspects and Applications. Front Immunol,
2018. 9 : p. 1070.
4. Arumugam, M.K., et al.,Beneficial Effects of Betaine: A Comprehensive Review. Biology
(Basel), 2021. 10 (6).
5. Kennedy, D.J., et al.,Substrate specificity and functional characterisation of the
H+/amino acid transporter rat PAT2 (Slc36a2). Br J Pharmacol, 2005.144 (1): p. 28-41.
6. Thwaites, D.T. and C.M. Anderson,The SLC36 family of proton-coupled amino acid transporters and
their potential role in drug transport. Br J Pharmacol, 2011.164 (7): p. 1802-16.
7. Knight, L.S., et al., Betaine
in the Brain: Characterization of Betaine Uptake, its Influence on Other
Osmolytes and its Potential Role in Neuroprotection from Osmotic
Stress. Neurochem Res, 2017. 42 (12): p. 3490-3503.
8. Slow, S., et al., Plasma
Dependent and Independent Accumulation of Betaine in Male and Female Rat
Tissues. 2009
9. Kharbanda, K.K., et al.,Betaine attenuates alcoholic steatosis by restoring
phosphatidylcholine generation via the phosphatidylethanolamine
methyltransferase pathway. J Hepatol, 2007. 46 (2): p. 314-21.
10. Teng, Y.W., et al., Mouse
betaine-homocysteine S-methyltransferase deficiency reduces body fat via
increasing energy expenditure and impairing lipid synthesis and
enhancing glucose oxidation in white adipose tissue. J Biol Chem, 2012.287 (20): p. 16187-98.
11. Ommati, M.M. and R. Heidari,Betaine, heavy metal protection, oxidative stress, and the liver ,
in Toxicology . 2021. p. 387-395.
12. Ismaeel, A., Effects of
betaine supplementation on muscle strength and power: A systematic
review. 2017.
13. Cholewa, J.M., et al., The
effects of chronic betaine supplementation on body composition and
performance in collegiate females: a double-blind, randomized, placebo
controlled trial. J Int Soc Sports Nutr, 2018. 15 (1): p. 37.
14. Willingham, B.D., T.J. Ragland,
and M.J. Ormsbee, Betaine Supplementation May Improve Heat
Tolerance: Potential Mechanisms in Humans. Nutrients, 2020.12 (10).
15. Kumar, T., G.S. Sharma, and L.R.
Singh, Homocystinuria: Therapeutic approach. Clin Chim Acta,
2016. 458 : p. 55-62.
16. Lawson-Yuen, A. and H.L. Levy,The use of betaine in the treatment of elevated homocysteine. Mol
Genet Metab, 2006. 88 (3): p. 201-7.
17. Cholewa, J.M., L.
Guimaraes-Ferreira, and N.E. Zanchi, Effects of betaine on
performance and body composition: a review of recent findings and
potential mechanisms. Amino Acids, 2014. 46 (8): p. 1785-93.
18. Forlani, G., et al., Three
kinds of currents in the canine betaine-GABA transporter BGT-1 expressed
in Xenopus laevis oocytes. 2001.
19. Kempson, S.A., Y. Zhou, and N.C.
Danbolt, The betaine/GABA transporter and betaine: roles in brain,
kidney, and liver. Front Physiol, 2014. 5 : p. 159.
20. Schwahn, B.C., et al.,Pharmacokinetics of oral betaine in healthy subjects and patients
with homocystinuria. Br J Clin Pharmacol, 2003. 55 (1): p.
6-13.
21. Atkinson, W., et al.,Dietary and supplementary betaine: acute effects on plasma betaine
and homocysteine concentrations under standard and postmethionine load
conditions in healthy male subjects. 2008.
22. Awwad, H.M., et al.,Measurement of concentrations of whole blood levels of choline,
betaine, and dimethylglycine and their relations to plasma levels. J
Chromatogr B Analyt Technol Biomed Life Sci, 2014. 957 : p.
41-5.
23. Kunisawa, K., et al.,Betaine attenuates memory impairment after water-immersion
restraint stress and is regulated by the GABAergic neuronal system in
the hippocampus. Eur J Pharmacol, 2017. 796 : p. 122-130.
24. Ghatak, S., et al., Novel
Therapeutic Approach for Excitatory/Inhibitory Imbalance in
Neurodevelopmental and Neurodegenerative Diseases. Annu Rev Pharmacol
Toxicol, 2021. 61 : p. 701-721.
25. Zhang, W., et al., The Role
of the GABAergic System in Diseases of the Central Nervous System.Neuroscience, 2021. 470 : p. 88-99.
26. Latka, K., J. Jonczyk, and M.
Bajda, Structure modeling of gamma-aminobutyric acid transporters
- Molecular basics of ligand selectivity. Int J Biol Macromol, 2020.
27. Zafar, S. and I. Jabeen,Structure, Function, and Modulation of gamma-Aminobutyric Acid
Transporter 1 (GAT1) in Neurological Disorders: A Pharmacoinformatic
Prospective. Front Chem, 2018. 6 : p. 397.
28. Schousboe, A., et al., Role
of the betaine/GABA transporter (BGT-1/GAT2) for the control of
epilepsy. Eur J Pharmacol, 2004. 500 (1-3): p. 281-7.
29. Smith, M.D., et al.,Inhibition of the betaine-GABA transporter (mGAT2/BGT-1) modulates
spontaneous electrographic bursting in the medial entorhinal cortex
(mEC). Epilepsy Res, 2008. 79 (1): p. 6-13.
30. Lehre, A.C., et al.,Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does
not affect seizure thresholds of adult mice. Epilepsy Res, 2011.95 (1-2): p. 70-81.
31. Malik, S., et al.,Biomarkers of Major Depressive Disorder: Knowing is Half the
Battle. Clin Psychopharmacol Neurosci, 2021. 19 (1): p. 12-25.
32. Trousselard, M., et al., Is
plasma GABA level a biomarker of Post-Traumatic Stress Disorder (PTSD)
severity? A preliminary study. Psychiatry Res, 2016. 241 : p.
273-9.
33. Kirischuk, S., et al.,Astrocyte sodium signaling and the regulation of
neurotransmission. Glia, 2016. 64 (10): p. 1655-66.
34. Lee, M., E.G. McGeer, and P.L.
McGeer, Mechanisms of GABA release from human astrocytes. Glia,
2011. 59 (11): p. 1600-11.
35. Bouter, Y., et al., Chronic
Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters
Endocannabinoid Levels in the Brain of C57Bl/6J Mice. Cannabis
Cannabinoid Res, 2020. 5 (1): p. 51-61.
36. Beery, A.K. and D. Kaufer,Stress, social behavior, and resilience: insights from rodents.Neurobiol Stress, 2015. 1 : p. 116-127.
37. Qu, Y., et al., Betaine
supplementation is associated with the resilience in mice after chronic
social defeat stress: a role of brain-gut-microbiota axis. J Affect
Disord, 2020. 272 : p. 66-76.
38. Singh, S., et al., Current
therapeutic strategy in Alzheimer’s disease. Eur Rev Med Pharmacol
Sci., 2012.
39. Hooshmand, B., et al.,Homocysteine and holotranscobalamin and the risk of Alzheimer
disease. 2010.
40. Chai, G.S., et al., Betaine
attenuates Alzheimer-like pathological changes and memory deficits
induced by homocysteine. J Neurochem, 2013. 124 (3): p. 388-96.
41. Liu, X.P., et al., Betaine
suppressed Abeta generation by altering amyloid precursor protein
processing. Neurol Sci, 2014. 35 (7): p. 1009-13.
42. Sun, J., et al.,Association between malnutrition and hyperhomocysteine in
Alzheimer’s disease patients and diet intervention of betaine. J Clin
Lab Anal, 2017. 31 (5).
43. Nie, C., et al., Betaine
reverses the memory impairments in a chronic cerebral hypoperfusion rat
model. Neurosci Lett, 2016. 615 : p. 9-14.
44. Shulman, L., Levodopa
Toxicity in Parkinson Disease: Reality or Myth? 2000.
45. Muller, T., et al.,Elevation of total homocysteine levels in patients with
Parkinson’s disease treated with duodenal levodopa/carbidopa gel. J
Neural Transm (Vienna), 2011. 118 (9): p. 1329-33.
46. Imamura, K., et al.,Homocysteine is toxic for dopaminergic neurons in primary
mesencephalic culture. 2007.
47. Chandra, G., et al., Acute
intranigral homocysteine administration produces stereotypic behavioral
changes and striatal dopamine depletion in Sprague-Dawley rats. Brain
Res, 2006. 1075 (1): p. 81-92.
48. Muller, T., et al.,Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after
repeat administration of levodopa/carbidopa with and without entacapone
in patients with Parkinson’s disease. J Neural Transm (Vienna), 2006.113 (10): p. 1441-8.
49. Alirezaei, M., et al.,Beneficial antioxidant properties of betaine against oxidative
stress mediated by levodopa/benserazide in the brain of rats. J Physiol
Sci, 2015. 65 (3): p. 243-52.
50. Amiraslani, B., et al.,Recognition of betaine as an inhibitor of
lipopolysaccharide-induced nitric oxide production in activated
microglial cells. Iran Biomed J, 2012. 16 (2): p. 84-9.
51. Im, A.R., et al., Betaine
protects against rotenone-induced neurotoxicity in PC12 cells. Cell Mol
Neurobiol, 2013. 33 (5): p. 625-35.
52. Li, Q., et al., Betaine
protects rats against ischemia/reperfusion injury-induced brain damage.J Neurophysiol, 2022. 127 (2): p. 444-451.
53. Kraepelin, E., Dementia
praecox and paraphrenia . 1919: Livingstone.
54. Suzuki-Abe, H., et al.,Metabolomic and pharmacologic analyses of brain substances
associated with sleep pressure in mice. Neurosci Res, 2022.177 : p. 16-24.
55. Yoshihara, S., et al.,Betaine ameliorates schizophrenic traits by functionally
compensating for KIF3-based CRMP2 transport. Cell Rep, 2021.35 (2): p. 108971.
56. Ohnishi, T., et al.,Investigation of betaine as a novel psychotherapeutic for
schizophrenia. EBioMedicine, 2019. 45 : p. 432-446.
57. Ibi, D., et al.,Involvement of GAT2/BGT-1 in the preventive effects of betaine on
cognitive impairment and brain oxidative stress in amyloid beta
peptide-injected mice. Eur J Pharmacol, 2019. 842 : p. 57-63.
58. Wu, B.T., et al., Early
second trimester maternal plasma choline and betaine are related to
measures of early cognitive development in term infants. PLoS One,
2012. 7 (8): p. e43448.
59. Caro, A.A. and A.I. Cederbaum,Antioxidant properties of S-adenosyl-L-methionine in
Fe(2+)-initiated oxidations. Free Radic Biol Med, 2004.36 (10): p. 1303-16.
60. Schwab, U., et al., Betaine
supplementation decreases plasma homocysteine concentrations but does
not affect body weight, body composition, or resting energy expenditure
in human subjects. 2002.
61. Millard, H.R., et al.,Dietary choline and betaine; associations with subclinical markers
of cardiovascular disease risk and incidence of CVD, coronary heart
disease and stroke: the Jackson Heart Study. Eur J Nutr, 2018.57 (1): p. 51-60.
62. Yang, Y., et al., High
Betaine and Dynamic Increase of Betaine Levels Are Both Associated With
Poor Prognosis of Patients With Pulmonary Hypertension. Front
Cardiovasc Med, 2022. 9 : p. 852009.
63. Mukherjee, S., Betaine and
nonalcoholic steatohepatitis: back to the future? World J
Gastroenterol, 2011. 17 (32): p. 3663-4.
64. Van Every, D.W., et al.,Betaine Supplementation: A Critical Review of Its Efficacy for
Improving Muscle Strength, Power, and Body Composition. Strength &
Conditioning Journal, 2021. 43 (4): p. 53-61.